Arturo MD Molina's Net Worth
$2.37 Million
Who is Arturo MD Molina?
Arturo MD Molina has an estimated net worth of $2.37 Million. This is based on reported shares across multiple companies, which include Cougar Biotechnology, Inc., SUTRO BIOPHARMA INC, Forma Therapeutics Holdings, Inc., and Protagonist Therapeutics, Inc.
SEC CIK
Arturo MD Molina's CIK is 0001398940
Past Insider Trading and Trends
2022 was Arturo MD Molina's most active year for acquiring shares with 10 total transactions. Arturo MD Molina's most active month to acquire stocks was the month of December. 2022 was Arturo MD Molina's most active year for disposing of shares, totalling 7 transactions. Arturo MD Molina's most active month to dispose stocks was the month of August. 2020 saw Arturo MD Molina paying a total of $49,995.25 for 83,560 shares, this is the most they've acquired in one year. In 2009 Arturo MD Molina cashed out on 225,000 shares for a total of $4,091,150.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Cougar Biotechnology, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
SUTRO BIOPHARMA, INC. (STRO) Snapshot price: $4.12
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.53% | 8.14K |
$8.17 | -$35,580.35 | 37.74K |
Mar 4 - Mar 5
| |||
Form 4
| +11.70% | 3.1K |
$10.39 | -$22,348.89 | 29.59K |
Jan 29
| |||
Form 4
| +27.01% | 5.63K |
$19.23 | -$57,228.48 | 26.49K |
Sep 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
| +17.74% | 3.14K |
$22.15 | -$46,670.05 | 20.86K |
Jan 29
| |||
Form 4
| +46.62% | 5.63K |
$10.30 | -$30,652.80 | 17.72K |
Sep 25
| |||
Form 4
| +114.54% | 6.45K |
$7.75 | $49,995.25 | 12.08K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
∞
| 5.63K |
$9.74 | -$28,986.24 | 5.63K |
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Forma Therapeutics Holdings, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.00K |
—
|
—
|
0
|
Oct 14
| |||
Form 4
| +81.82% | 4.5K |
—
|
—
| 10K |
Jun 8
| |||
Form 4
|
∞
| 5.5K |
—
|
—
| 5.5K |
Jan 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Protagonist Therapeutics, Inc (PTGX) Snapshot price: $41.5
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.88% | -427.00 |
$24.63 | -$10,517.01 | 48.35K |
Jan 16
| |||
Form 4
| +100.11% | 24.4K |
$16.24 | -$30,011.52 | 48.78K |
Nov 15 - Jan 2
| |||
Form 4
| +14.71% | 3.13K |
—
|
—
| 24.38K |
Jan 16
| |||
Form 4
|
∞
| 21.25K |
—
|
—
| 21.25K |
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |